





























Loading banners
Loading banners...


NEWS EXPRESS is Nigeria’s leading online newspaper. Published by Africa’s international award-winning journalist, Mr. Isaac Umunna, NEWS EXPRESS is Nigeria’s first truly professional online daily newspaper. It is published from Lagos, Nigeria’s economic and media hub, and has a provision for occasional special print editions. Thanks to our vast network of sources and dedicated team of professional journalists and contributors spread across Nigeria and overseas, NEWS EXPRESS has become synonymous with newsbreaks and exclusive stories from around the world.

Dr Salihu Ibrahim Isma’il, Department of Biochemistry, Federal University Dutse (FUD), Jigawa, has developed a herbal anti-diabetic and anti-cancer drugs.
The Vice-Chancellor of the university, Prof. Fatima Batul-Muktar, disclosed this at a newsmen conference in Dutse on Monday.
“I am glad to inform you that one of our staff, Dr Salihu Ibrahim Isma’il of the Biochemistry Department has developed a herbal anti-diabetic and anti-cancer drugs,” Fatima-Batul said.
The vice chancellor said that the anti-diabetic drug has successfully passed a pre-clinical stage.
She added that it has also gotten ethical approval for clinical trial by Kano State Hospitals Management Board (KSHMB).
According to her, the clinical trial will soon commence at Muhammad Abdullahi Wase Specialist Hospital (MAWSH), Kano.
Batul-Muktar, who identified research as one of the important works of a university, noted the varsity’s academic staffers have successfully completed 16 research works in different fields since its establishemet in 2011, adding “19 research works are currently ongoing”.
According to Batul-Muktar, the Tertiary Education Trust Fund (Tetfund), has released N178,956,970 million to the varsity for Academic Staff Training and Development (AST&D).
She further revealed that 11 academic staff are currently on local fellowship pursuing their PhDs, six on foreign scholarship and 17 academic staff have benefitted from conference attendance. (NAN)